Exscientia stock.

Exscientia Stock Up 2.1 %. NASDAQ:EXAI opened at $5.40 on Wednesday. The firm’s 50 day simple moving average is $5.70 and its 200 day simple moving average is $6.18. The company has a debt-to ...That was the dynamic behind artificial intelligence (AI)-powered healthcare-solutions provider Exscientia 's ( EXAI 1.15%) more than 6% leap in share price on Wednesday. That made the stock quite ...How much is Exscientia stock worth today? ( NASDAQ: EXAI) Exscientia currently has 124,511,492 outstanding shares. With Exscientia stock trading at $6.17 per share, the total value of Exscientia stock (market capitalization) is $768.24M. Exscientia stock was originally listed at a price of $27.10 in Oct 1, 2021.These 4 analysts have an average price target of $14.0 versus the current price of Exscientia at $6.1, implying upside. Below is a summary of how these 4 analysts rated Exscientia over the past 3 ...

OXFORD, England--(BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) today announced that it has enrolled the first patient in its Phase 1/2 “ELUCIDATE” (GTAEXS617-001) study evaluating GTAEXS617 (‘617), Exscientia’s precision-designed CDK7 inhibitor, for the treatment of advanced solid tumours. The clinical trial will evaluate …Can Exscientia Stock Earn a Higher Valuation? ... Exscientia held $720 million in cash, had 33 active programs, and 12 drug development collaborations at the end of March 2022.4 окт. 2021 г. ... The Oxford, U.K.-based company offered more than 13.8 million American depositary shares priced at $22 apiece, which was the top end of the ...

Overview | EXAI U.S.: Nasdaq Exscientia PLC ADR Watch NEW Set a price target alert Premarket Last Updated: Nov 30, 2023 5:47 a.m. EST Delayed quote $ 6.01 0.01 0.17% Before Hours Volume: 87... 20 сент. 2023 г. ... Exscientia's stock (NASDAQ:EXAI) struggled on Sept. 20, with shares closing 10.4% downward at $4.53 each. Benevolentai deal. Benevolentai and ...

Mar 10, 2023 · This free interactive report on Exscientia's balance sheet strength is a great place to start, if you want to investigate the stock further.. A Different Perspective. Exscientia shareholders are ... OXFORD, England--(BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) today announced two new wholly-owned precision oncology development candidates, EXS74539 (‘539), an LSD1 inhibitor, and EXS73565 ('565), a MALT1 protease inhibitor. These compounds have been precision designed to improve the potential for patient …In the last 3 months, 7 analysts have offered 12-month price targets for Exscientia. The company has an average price target of $12.86 with a high of $14.00 and a low of $7.00. Below is a summary ...Overview | EXAI U.S.: Nasdaq Exscientia PLC ADR Watch NEW Set a price target alert Premarket Last Updated: Nov 30, 2023 5:47 a.m. EST Delayed quote $ 6.01 0.01 0.17% Before Hours Volume: 87...

Recent advancements in the Company’s pipeline, collaborations and operations as well as financial results for the fourth quarter and full year 2021 are summarised below. In addition, Exscientia will host a conference call on Thursday, March 24 at 12:30 p.m. GMT / 8:30 a.m. ET to provide an overview of the company's end-to-end technology ...

Nov 9, 2023 · Revenue: Revenue for the three and nine months ended September 30, 2023 was $10.8 million and $21.6 million respectively, compared to $7.7 million and $24.9 million for the three and nine months ...

MarketWatchIn the last 3 months, 7 analysts have offered 12-month price targets for Exscientia. The company has an average price target of $12.86 with a high of $14.00 and a low of $7.00. Below is a summary ...The share price of Exscientia plc (EXAI) now. What analysts predict: $9.5. 52-week High/Low: $11.52 / $4.09. 50/200 Day Moving Average: $5.22 / $6.25. This figure corresponds to the Average Price over the previous 50/200 days. For Exscientia stocks, the 50-day moving average is the support level today. For Exscientia stocks, the 200 …Exscientia has raised a total of. $374.4M. in funding over 8 rounds. Their latest funding was raised on Jul 8, 2021 from a Grant round. Exscientia is registered under the ticker NASDAQ:EXAI . Their stock opened with $22.00 in its Oct 1, 2021 IPO. Exscientia is funded by 17 investors. Bill & Melinda Gates Foundation and Hongyou Investment are ...Company profile page for Exscientia Plc including stock price, company news, executives, board members, and contact informationOXFORD, U.K., March 23, 2023 -- ( BUSINESS WIRE )--Exscientia plc (Nasdaq: EXAI) Recent developments in the Company’s pipeline, collaborations, and operations as well as financial results for ...

Get the latest information on Exscientia PLC ADR (EXAI), a biotechnology company that uses AI to design novel drug candidates. See the stock price, news, …6 окт. 2021 г. ... Shares of Exscientia now trade on the Nasdaq under the stock symbol EXAI, and have dipped around 16% from $27.10 on its debut last Friday to ...Successfully navigating the dynamic landscape of stock investing requires an understanding of factors like momentum to judge a stock’s price trend. In this article, we take an in-depth look at Exscientia PLC (ADR) (EXAI) to unravel why momentum evaluation plays a crucial role in making savvy investment choices.OXFORD, U.K., March 23, 2023 -- ( BUSINESS WIRE )--Exscientia plc (Nasdaq: EXAI) Recent developments in the Company’s pipeline, collaborations, and operations as well as financial results for ...Shares of Exscientia PLC Sponsored ADR (EXAI) have gained 7.6% over the past four weeks to close the last trading session at $5.40, but there could still be a solid upside left in the stock if ...

That was the dynamic behind artificial intelligence (AI)-powered healthcare-solutions provider Exscientia 's ( EXAI 1.15%) more than 6% leap in share price on Wednesday. That made the stock quite ...

Nov 14, 2023 · Exscientia PLC (ADR) Stock Price History. Exscientia PLC (ADR)’s price is currently up 7.78% so far this month. During the month of November, Exscientia PLC (ADR)’s stock price has reached a high of $6.10 and a low of $4.95. Over the last year, Exscientia PLC (ADR) has hit prices as high as $11.52 and as low as $4.09. Year to date ... EXS73565. MALT1. * Phase 3 may not be required if Phase 2 is registrational: PKC-theta is in a Phase 1 healthy volunteer study. Does not include Sumitomo Pharma programmes. Our pipeline demonstrates our ability to rapidly translate scientific concepts and patient-centric data into precision-designed therapeutic candidates. OXFORD, England--(BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) today announced that EXS4318 ('4318) a compound precision designed by Exscientia and in-licensed by Bristol Myers Squibb in August 2021, has entered Phase 1 clinical trials in the United States. The compound is in development for immunology & inflammation (I&I) …Feb 6, 2023 · Bristol Myers Squibb will oversee the clinical and commercial development and Exscientia, who designed the PKC theta inhibitor, is eligible for milestone payments and, if approved, tiered royalties on net product sales. In May 2021, Bristol Myers Squibb and Exscientia expanded the collaboration in immunology & inflammation indications and oncology. Oct 19, 2023 · Successfully navigating the dynamic landscape of stock investing requires an understanding of factors like momentum to judge a stock’s price trend. In this article, we take an in-depth look at Exscientia PLC (ADR) (EXAI) to unravel why momentum evaluation plays a crucial role in making savvy investment choices. Like Recursion, Exscientia (NYSE: EXAI) uses AI in its approach to drug discovery.Unlike Recusion, Exscientia aims to develop bespoke drug solutions for patients. Exscientia was the first to bring ...Mar 7, 2023 · Exscientia PLC (ADR) Stock Price History. Exscientia PLC (ADR)’s price is currently up 5.38% so far this month. During the month of March, Exscientia PLC (ADR)’s stock price has reached a high of $7.11 and a low of $6.02. Over the last year, Exscientia PLC (ADR) has hit prices as high as $17.66 and as low as $4.09. Year to date, Exscientia ... View Exscientia PLC Sponsored ADR EXAI investment & stock information. Get the latest Exscientia PLC Sponsored ADR EXAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Shares of Exscientia PLC Sponsored ADR (EXAI) have gained 7.6% over the past four weeks to close the last trading session at $5.40, but there could still be a solid upside left in the stock if ...First AI platform clinically validated to improve treatment outcomes in prospective study. Exscientia, a clinical stage pharmatech company, has entered into a binding agreement to acquire Allcyte, a leader in artificial intelligence (AI) based precision medicine. The combination expands Exscientia’s translational capabilities by enabling …

13 сент. 2021 г. ... After penning a major funding round earlier this year, the artificial intelligence-powered drug designer Exscientia ... Share. molecule ...

Successfully navigating the dynamic landscape of stock investing requires an understanding of factors like momentum to judge a stock’s price trend. In this article, we take an in-depth look at Exscientia PLC (ADR) (EXAI) to unravel why momentum evaluation plays a crucial role in making savvy investment choices.

The Schrödinger Building Oxford Science Park, Oxford OX4 4GE . Phone: +44 (0) 1865 818941OXFORD, England-- (BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) will report financial results for the second quarter ended June 30, 2023, on Thursday August 10, 2023, before the open of U.S. markets. The Company will host a conference call and webcast at 1:30 p.m. BST / 8:30 a.m. EDT to provide a business update and review …6 июл. 2023 г. ... In October 2021, Exscientia was floated on the Nasdaq stock market, raising $510 million, the largest initial public offering for a European ...EVOTEC TO INVEST EUR 15 M IN EXSCIENTIA, A PIONEER OF ARTIFICIAL INTELLIGENCE ("AI") IN DRUG DISCOVERY ... Hamburg, Germany, Dundee, UK, 28 September 2017: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and Exscientia Ltd ("Exscientia") today announced that Evotec has …This results in a target price of $34.4 (12.74 x 2.7) based on the current share price. This is a high target in view of current market conditions where stocks with negative earnings are being ...Exscientia PLC (ADR) Stock Price History. Exscientia PLC (ADR)’s price is currently down 14.9% so far this month. During the month of March, Exscientia PLC (ADR)’s stock price has reached a high of $7.11 and a low of $5.50. Over the last year, Exscientia PLC (ADR) has hit prices as high as $16.45 and as low as $4.09. Year to date ...Best-in-Class Portfolio Monitoring. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts.Legal Name Exscientia Ltd. Stock Symbol NASDAQ:EXAI. Company Type For Profit. Contact Email [email protected]. Phone Number +44-1865-818941. Exscientia …One reason for this week's share growth was the company's first-quarter earnings report. Its reported revenue of $7.1 million was down 17.4% year over year, and its net loss was $46.6 million, 143 ...Real time Exscientia Plc (EXAI) stock price quote, stock graph, news & analysis.

Jul 11, 2023 · The Schrödinger Building Oxford Science Park, Oxford OX4 4GE . Phone: +44 (0) 1865 818941 If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.The first-quarter loss widened to $46.6 million or $0.38 per share from $19.1 million or $0.16 per share of last year. Revenue decreased to $7.1 million from $8.6 million last year. R&D expenses ...Instagram:https://instagram. ltd stockautotrader stockbest tech stock to buy nowaetna dental access savings plan Jul 11, 2023 · The Schrödinger Building Oxford Science Park, Oxford OX4 4GE . Phone: +44 (0) 1865 818941 cost of mailing a letterwhere can i trade otc stocks In October 2021, Exscientia was floated on the Nasdaq stock market, raising $510 million, the largest initial public offering for a European biotech ever. From small beginnings, with just five staff, Exscientia now employs over 400 people.Description. Exscientia PLC is engaged in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of novel therapeutic compounds. The company's technology platform combines human and computational capabilities to accelerate the process of designing novel, safe and efficacious compounds for clinical ... rubber stocks Mar 10, 2023 · This free interactive report on Exscientia's balance sheet strength is a great place to start, if you want to investigate the stock further.. A Different Perspective. Exscientia shareholders are ... The mean of analysts' price targets for Exscientia PLC Sponsored ADR (EXAI) points to a 68% upside in the stock. While this highly sought-after metric has not …